Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Vatalanib> ?p ?o }
- Vatalanib abstract "Vatalanib (INN, codenamed PTK787 or PTK/ZK) is a small molecule protein kinase inhibitor that inhibits angiogenesis. It is being studied as a possible treatment for several types of cancer, particularly cancer that is at an advanced stage or has not responded to chemotherapy. Vatalanib is orally active, that is, it is effective when taken by mouth.Vatalanib is being developed by Bayer Schering and Novartis. It inhibits all known VEGF receptors, as well as platelet-derived growth factor receptor-beta and c-kit, but is most selective for VEGFR-2.".
- Vatalanib atcPrefix "none".
- Vatalanib casNumber "212141-54-3".
- Vatalanib fdaUniiCode "5DX9U76296".
- Vatalanib iupacName "N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin- 1-amine".
- Vatalanib pubchem "151194".
- Vatalanib thumbnail Vatalanib.svg?width=300.
- Vatalanib wikiPageExternalLink results?intr=%22Vatalanib%22.
- Vatalanib wikiPageID "20341296".
- Vatalanib wikiPageLength "6035".
- Vatalanib wikiPageOutDegree "47".
- Vatalanib wikiPageRevisionID "679111070".
- Vatalanib wikiPageWikiLink Adverse_drug_reaction.
- Vatalanib wikiPageWikiLink Angiogenesis.
- Vatalanib wikiPageWikiLink Angiogenesis_inhibitor.
- Vatalanib wikiPageWikiLink Bayer_Schering_Pharma.
- Vatalanib wikiPageWikiLink C-kit.
- Vatalanib wikiPageWikiLink CD117.
- Vatalanib wikiPageWikiLink CYP3A4.
- Vatalanib wikiPageWikiLink Cancer.
- Vatalanib wikiPageWikiLink Category:Angiogenesis_inhibitors.
- Vatalanib wikiPageWikiLink Category:Experimental_cancer_drugs.
- Vatalanib wikiPageWikiLink Category:Tyrosine_kinase_inhibitors.
- Vatalanib wikiPageWikiLink Chemotherapy.
- Vatalanib wikiPageWikiLink Chemotherapy_regimen.
- Vatalanib wikiPageWikiLink Clinical_endpoint.
- Vatalanib wikiPageWikiLink Clinical_trial.
- Vatalanib wikiPageWikiLink Colorectal_cancer.
- Vatalanib wikiPageWikiLink Diarrhea.
- Vatalanib wikiPageWikiLink Dizziness.
- Vatalanib wikiPageWikiLink Drug_discovery.
- Vatalanib wikiPageWikiLink Enzyme.
- Vatalanib wikiPageWikiLink FOLFOX.
- Vatalanib wikiPageWikiLink Fatigue_(medical).
- Vatalanib wikiPageWikiLink First-line_treatment.
- Vatalanib wikiPageWikiLink High-throughput_screening.
- Vatalanib wikiPageWikiLink Hypertension.
- Vatalanib wikiPageWikiLink International_Nonproprietary_Name.
- Vatalanib wikiPageWikiLink Irinotecan.
- Vatalanib wikiPageWikiLink Kidney.
- Vatalanib wikiPageWikiLink Kinase_insert_domain_receptor.
- Vatalanib wikiPageWikiLink Lactate_dehydrogenase.
- Vatalanib wikiPageWikiLink Liver.
- Vatalanib wikiPageWikiLink Metastasis.
- Vatalanib wikiPageWikiLink National_Institutes_of_Health.
- Vatalanib wikiPageWikiLink Nausea.
- Vatalanib wikiPageWikiLink Novartis.
- Vatalanib wikiPageWikiLink Platelet-derived_growth_factor_receptor.
- Vatalanib wikiPageWikiLink Progression-free_survival.
- Vatalanib wikiPageWikiLink Progression_Free_Survival.
- Vatalanib wikiPageWikiLink Protein_kinase_inhibitor.
- Vatalanib wikiPageWikiLink Pyrimidine_analogue.
- Vatalanib wikiPageWikiLink Randomized_controlled_trial.
- Vatalanib wikiPageWikiLink Small_molecule.
- Vatalanib wikiPageWikiLink Statistical_significance.
- Vatalanib wikiPageWikiLink Therapy.
- Vatalanib wikiPageWikiLink VEGF_receptors.
- Vatalanib wikiPageWikiLink Vomiting.
- Vatalanib wikiPageWikiLinkText "Vatalanib".
- Vatalanib wikiPageWikiLinkText "vatalanib".
- Vatalanib atcPrefix "none".
- Vatalanib bioavailability "High".
- Vatalanib c "20".
- Vatalanib casNumber "212141".
- Vatalanib chembl "101253".
- Vatalanib chemspiderid "133257".
- Vatalanib cl "1".
- Vatalanib eliminationHalfLife "3960.0".
- Vatalanib excretion "Fecal and renal".
- Vatalanib h "15".
- Vatalanib hasPhotoCollection Vatalanib.
- Vatalanib iupacName "N--4-phthalazin- 1-amine".
- Vatalanib iupharLigand "5705".
- Vatalanib legalStatus "Investigational".
- Vatalanib metabolism "Extensive hepatic metabolism".
- Vatalanib molecularWeight "346.813".
- Vatalanib n "4".
- Vatalanib pregnancyCategory "None assigned".
- Vatalanib pubchem "151194".
- Vatalanib routesOfAdministration "Oral".
- Vatalanib smiles "Clc1cccNc3nncCc4ccncc4".
- Vatalanib unii "5".
- Vatalanib width "180".
- Vatalanib wikiPageUsesTemplate Template:Chemotherapeutic_agents.
- Vatalanib wikiPageUsesTemplate Template:Distinguish.
- Vatalanib wikiPageUsesTemplate Template:Drugbox.
- Vatalanib wikiPageUsesTemplate Template:Reflist.
- Vatalanib subject Category:Angiogenesis_inhibitors.
- Vatalanib subject Category:Experimental_cancer_drugs.
- Vatalanib subject Category:Tyrosine_kinase_inhibitors.
- Vatalanib hypernym Inhibitor.
- Vatalanib type ChemicalSubstance.
- Vatalanib type Drug.
- Vatalanib type Drug.
- Vatalanib type Inhibitor.
- Vatalanib type ChemicalObject.
- Vatalanib type Thing.
- Vatalanib type Q8386.
- Vatalanib comment "Vatalanib (INN, codenamed PTK787 or PTK/ZK) is a small molecule protein kinase inhibitor that inhibits angiogenesis. It is being studied as a possible treatment for several types of cancer, particularly cancer that is at an advanced stage or has not responded to chemotherapy. Vatalanib is orally active, that is, it is effective when taken by mouth.Vatalanib is being developed by Bayer Schering and Novartis.".
- Vatalanib label "Vatalanib".